Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesComparison of incidences of cardiovascular events among new users of different statins: a retrospective observational cohort study
Current Medical Research and Opinion, 09/25/09
Heintjes EM et al. – Compared to other statin users without recent prior cardiovascular events, the incidence of fatal and non–fatal CVD in this retrospective observational cohort study was 28% lower among rosuvastatin users.
Related Articles
Assessment of gender-specific preventive cardiovascular knowledge among house staff: Potential impact on cardiovascular management
Gender Medicine, 10/26/09
Relevance Score: 89%
Measuring health-related quality of life in Hungarian children attending a cardiology clinic with the Pediatric Quality of Life Inventory
European Journal of Pediatrics, 10/12/09
Relevance Score: 89%
Does digital flat detector technology tip the scale towards better image quality or reduced patient dose in interventional cardiology
European Journal of Radiology, 11/20/09
Relevance Score: 87%
Causes of death and cardiovascular complications in adolescents and adults with congenitally malformed hearts: an autopsy study of 102 cases
Cardiology in the Young, 10/19/09
Relevance Score: 84%
Cardiomyopathies in Propionic Aciduria are Reversible After Liver Transplantation
The Journal of Pediatrics, 10/13/09
Relevance Score: 84%
Today in Cardiac/Hypertension...keeping you current
Receive free subspecialty "5-minute updates" via email
Interferon-gamma (INF-gamma) release test can detect cutaneous adverse effects to statins
International Journal of Dermatology, 12/03/09
Valsartan and aliskiren (Valturna): Combination of an angiotensin receptor blocker with direct renin inhibitor approved for the treatment of hypertension
Formulary , 12/02/09
Management of hypertension with fixed dose combinations of candesartan cilexetil and hydrochlorothiazide: patient perspectives and clinical utility
Vascular Health and Risk Management, 12/01/09
Sponsor
Article Search
Sponsor